Triple-marker PCR assay of sentinel lymph node as a prognostic factor in melanoma

Sentinel Lymph Node Mapping in Melanoma

(2014) Gianpiero Manca et al.   CLINICAL NUCLEAR MEDICINE

Long-term Follow-up and Survival of Patients Following a Recurrence of Melanoma After a Negative Sentinel Lymph Node Biopsy Result

(2013) Edward L. Jones et al.   JAMA Surgery

Melanoma survival in the United States, 1992 to 2005

(2011) Lori A. Pollack et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999-2006

(2011) Xiao-Cheng Wu et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The prognostic value of a reverse transcriptase-PCR assay of sentinel lymph node biopsy for patients with cutaneous melanoma

(2011) Takamichi Ito et al.   MELANOMA RESEARCH

Factors Associated with False-Negative Sentinel Lymph Node Biopsy in Melanoma Patients

(2010) Charles R. Scoggins et al.   ANNALS OF SURGICAL ONCOLOGY

Significance of sentinel lymph node biopsy in malignant melanoma: overview of international data

(2009) Yoichi Moroi   International Journal of Clinical Oncology

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular Staging of Pathologically Negative Sentinel Lymph Nodes from Melanoma Patients Using Multimarker, Quantitative Real-Time RT-PCR

(2008) Josep M. Hilari et al.   ANNALS OF SURGICAL ONCOLOGY